Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Milan
Clinical trial register · Italy

Clinical Trials in Milan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 26 Roma 23 Rome 19 Naples 17 Bologna 14
Narrow the registerReset
Recruitment status
Phase
Site location
Milan26 Roma23 Rome19 Naples17 Bologna14
All 70 locations
Target enrolment
to

Trials with a site in Milan

26 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Pfizer
Phase 2
24
Bergamo, Milan, Florence
2026-05-28
Recruiting
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
NCT07392892Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, Esophageal Adenocarcinoma
Pfizer
Phase 2/3
840
Milan
2026-05-14
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
1,410
Naples, Misterbianco, Meldola, Milan, Fano, Aviano, Roma, Brescia
2026-01-06
Recruiting
Pfizer
Phase 3
800
Tricase, Roma, Padova, Florence, Milan
2025-12-11
Recruiting
Pfizer
Phase 2/3
982
Milan, Florence, Ancona, Foggia
2025-10-03
Recruiting
Pfizer
Phase 3
1,000
Meldola, Ravenna, Rozzano, Orbassano, Rome, Milan, Novara, Padova
2025-09-28
Recruiting
Pfizer
Phase 3
723
Avezzano, Rome, Bologna, Florence, Milan, Pavia, Roma
2025-03-11
Active, closed
Pfizer
Phase 3
1,035
Bologna, Meldola(FC), Rome, Florence, Milan, Novara, Padova, Roma
2025-01-06
Active, closed
Pfizer
Phase 3
200
L’Aquila, Bari, Milan, Rome, Brescia, Latina, Pavia, Roma
2024-11-15
Recruiting
Pfizer
Phase 3
900
Meldola, Rome, Rozzano, Cremona, Milan, Naples, Terni, Trento
2024-10-22
Active, closed
Pfizer
Phase 3
1,571
L’Aquila, Florence, Milan, Roma, Rome, Cagliari
2023-11-08
Active, closed
Pfizer
Phase 2
108
Monserrato, Naples, Guastalla, San Giovanni Rotondo, Milan, Candiolo, Livorno, Pisa
2022-07-11
Recruiting
Pfizer
Phase 4
210
Bari, Perugia, Rome, Candiolo, Padova, Bologna, Milan, Naples
2022-07-05
Active, closed
Pfizer
Phase 3
854
Meldola, Rome, Milan, Catania, Siena, Ancona, Bologna, Roma
2022-03-25
Recruiting
Pfizer
Phase 3
640
Bari, Brescia, Latina, Rome, Milan
2022-02-28
Recruiting
Pfizer
Phase 3
245
Genoa, Rozzano, Roma, Milan
2021-11-17
Recruiting
Pfizer
Phase 3
893
Meldola, Milan, Monza, Catania, Bologna, Genova, Roma
2021-10-04
Active, closed
Pfizer
Phase 3
77
Milan, Rozzano, Ancona
2021-09-29
Active, closed
Pfizer
Phase 3
257
Udine, Milan, San Sisto, Roma, Rome, Siena, Candiolo, Bari
2021-01-15
Active, closed
Pfizer
Phase 3
841
Monserrato (CA), San Giovanni Rotondo, Milan, Candiolo, Orbassano, Brescia, Naples, Padova
2020-12-21
Active, closed
Pfizer
Phase 3
896
Castellana Grotte, Brescia, Milan, San Donato Milanese, Rho, Modena, Florence, Negrar(vr)
2019-09-05
Active, closed
Pfizer
Phase 3
296
Catania, Monza, Milan, Rozzano, Perugia, Pordenone, Parma, Roma
2017-04-27
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/milan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Milan that also match the filters currently applied.

How many clinical trials are recruiting in Milan?

15 of the 26 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Milan), 26 studies
PhaseStudiesRecruitingShare
Phase 3211180.8%
Phase 2217.7%
Phase 2/3227.7%
Phase 4113.8%

Most active sponsors

Lead sponsors with the most studies (Milan)
Lead sponsorStudiesRecruiting
Pfizer2615
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.